Skip to content
Clinical Trials – home
Sponsor

Abbott Biologicals B.V.

The Netherlands C. J. Van Houtenlaan 36, 1381 CP, The Netherlands

About the sponsor

The sponsor demonstrates a focused commitment to advancing therapeutic solutions in the field of immunology and infectious disease prevention. Research activities encompass the development of biological interventions designed to enhance immune system responses and protect against pathogenic threats. The organisation's work in this domain reflects a strategic emphasis on vaccine development and immunization strategies that address significant public health challenges across multiple geographical regions.

  • Vaccine immunogenicity and efficacy evaluation
  • Preventive biologics for infectious diseases
  • Immune response characterization

The international scope of research activities, spanning multiple continents, underscores a commitment to addressing global health priorities through biological therapeutics. The sponsor's portfolio reflects expertise in developing interventions that stimulate adaptive immunity and provide protection against transmissible diseases, contributing to broader efforts in communicable disease control and population health protection.

About Specializations

Abbott Biologicals B.V. runs clinical trials in conditions such as Influenza immunisation, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:A/Victoria/4897/2022 (H1N1)Pdm09-Like Strain (A/Victoria/4897/2022, Ivr-238)
  • Sponsor:Abbott Biologicals B.V.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).